Gene Logic to Present at the 2005 Rodman and Renshaw Techvest 7th Annual Healthcare Conference
November 02 2005 - 7:30AM
Business Wire
Gene Logic Inc. (NASDAQ:GLGC) announced today that its Chief
Executive Officer and President, Mark D. Gessler, will present at
the 2005 Rodman and Renshaw Techvest 7th Annual Healthcare
Conference. The presentation will be held at the New York Palace
Hotel on Wednesday, November 9, 2005, and Mr. Gessler's
presentation will begin at 11:55 a.m. (ET). The presentation will
be webcast live and can be accessed at www.genelogic.com under
Investors/Company Overview. The webcast will be archived for 30
days following the presentation and will be available under
Investors/Webcasts. Gene Logic Overview Gene Logic is leading the
transformation of pharmaceutical research and development with its
extensive gene expression databases, pioneering efforts in
toxicogenomics, sophisticated bioinformatics expertise, specialty
non-clinical testing capabilities and cutting edge technology
program for drug repositioning. Gene Logic technologies and
services are used by many of the world's top pharmaceutical and
biotechnology companies. Over 150 organizations and government
agencies have benefited from Gene Logic's diverse portfolio of drug
development services, enabling them to make more informed, more
reliable and more predictive decisions at each point in the highly
complex and costly drug development process. Founded in 1994, Gene
Logic is headquartered in Gaithersburg, Md., with additional
research and development facilities in Cambridge, Mass. and
Berkeley, Calif. The Company maintains customer support operations
in Europe and Asia and currently has about 450 employees worldwide.
For more information, visit www.genelogic.com or call toll-free -
1/800/GENELOGIC.
Gene Logic Inc. (MM) (NASDAQ:GLGC)
Historical Stock Chart
From Jul 2024 to Aug 2024
Gene Logic Inc. (MM) (NASDAQ:GLGC)
Historical Stock Chart
From Aug 2023 to Aug 2024